NCT07104773 is a NA clinical trial of Control Lens (omafilcon A) in Ametropia, sponsored by CooperVision International Limited (CVIL).

Who is sponsoring NCT07104773?

NCT07104773 is sponsored by CooperVision International Limited (CVIL).

What drugs are being tested in NCT07104773?

Interventions in NCT07104773: Control Lens (omafilcon A), Test Lens (stenfilcon A).

What condition does NCT07104773 study?

NCT07104773 studies Ametropia, Myopia.

Is NCT07104773 still recruiting?

NCT07104773 is currently completed. Last updated 8 April 2026.

Last reviewed 2026-04-08 · How we verify

NCT07104773

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses

Completed NA Last updated 8 April 2026

What this trial tests

NA trial testing Control Lens (omafilcon A) in Ametropia in 44 participants. Completed in 21 August 2025.

Timeline

24 July 2025

Primary endpoint
21 August 2025

21 August 2025

Quick facts

Lead sponsor	CooperVision International Limited (CVIL)
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	44
Start date	24 July 2025
Primary completion	21 August 2025
Estimated completion	21 August 2025
Sites	1 location across Canada

Drugs / interventions tested

Control Lens (omafilcon A)
Test Lens (stenfilcon A)

Conditions studied

Ametropia — all drugs for Ametropia →
Myopia — all drugs for Myopia →

Sponsor

CooperVision International Limited (CVIL) — full company profile →

Who can join

18 and older, any sex, with Ametropia or Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate and compare the performance of two soft contact lenses.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ametropia

Currently open trials in the same condition.

NCT06668246 — Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) · active not recruiting
NCT04632784 — Clinical Trial With Artiflex Presbyopic (Artiplus) · NA · active not recruiting

Other CooperVision International Limited (CVIL) trials

Trials by the same sponsor.

NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
NCT07276347 — Comprehensive Assessment of Multiple Products (CAMP) · NA · completed
NCT06873048 — Short-term Study of Two Soft Contact Lenses in Wearers With Low Astigmatism · NA · completed
NCT06869044 — A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add · NA · completed
NCT06758089 — A Clinical Comparison of Two Soft Toric Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07104773 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CooperVision International Limited (CVIL)
Last refreshed: 8 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07104773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing